| Pharmaceutical active ingredients: |
| Lamivudine |
| Available forms, composition and doses of Epivir-HBV: |
| Solution; Oral; Lamivudine 5 mg / mlTablets; Oral; Lamivudine 100 mg |
| Epivir-HBV medical category: |
| Human:AntiviralsNucleoside and nucleotide reverse transcriptase inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J05AF05 - Lamivudine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKlineShire |
| Related documents and information about Epivir-HBV: |
| Epivir prescribing information (PDF)Epivir-HBV prescribing information (PDF) |